(EMAILWIRE.COM, July 22, 2017 ) The point-of-care diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, at a CAGR of 9.8% during the forecast period. Rise in the prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across the globe are key factors fueling the growth of the market across the globe. Private investments and venture funding towards the development of new products along with the growing government support to increase the adoption of POC devices are boosting market growth. However, pricing pressures owing to reimbursement cuts and budget constraints hampering profits of these devices is restraining the growth of this market.
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

Emerging markets including China, India, and Brazil offer high growth potential for companies engaged in the development and distribution of point-of-care diagnostic devices. Growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures among POC providers are the key factors propelling the growth of point-of-care diagnostics market in the emerging countries.

Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key players in the market.

Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=106829185

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product in emerging nations. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment.

Target Audience:

Point-of-care diagnostic manufacturing companies
Clinical laboratories
Hospitals, clinics, and special areas (such as sports and military)
Research institutes and clinical research organizations (CROs)
Market research and consulting firms

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.